mRNA expression levels of the biological factors uPAR, uPAR-del4/5, and rab31, displaying prognostic value in breast cancer, are not clinically relevant in advanced ovarian cancer. (Q55054756)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	mRNA expression levels of the biological factors uPAR, uPAR-del4/5, and rab31, displaying prognostic value in breast cancer, are not clinically relevant in advanced ovarian cancer.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/21848504

mRNA expression levels of the biological factors uPAR, uPAR-del4/5, and rab31, displaying prognostic value in breast cancer, are not clinically relevant in advanced ovarian cancer. (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/21848504

1 reference

based on heuristic

inferred from title

Barbara Schmalfeldt

4

object named as

Barbara Schmalfeldt

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/21848504

author name string

Matthias Kotzsch

1

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/21848504

Julia Dorn

2

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/21848504

Kristina Doetzer

3

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/21848504

Janna Krol

5

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/21848504

Gustavo Baretton

6

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/21848504

Marion Kiechle

7

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/21848504

Manfred Schmitt

8

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/21848504

Viktor Magdolen

9

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/21848504

publication date

1 November 2011

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/21848504

Biological Chemistry

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/21848504

392

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/21848504

11

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/21848504

1047-1051

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/21848504

Translational research on u-PAR.

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.166

21 January 2018

The urokinase receptor: focused cell surface proteolysis, cell adhesion and signaling

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.166

21 January 2018

The RAB25 small GTPase determines aggressiveness of ovarian and breast cancers

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.166

21 January 2018

Emerging role of RAB GTPases in cancer and human disease

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.166

21 January 2018

Primary tumor levels of human tissue kallikreins affect surgical success and survival in ovarian cancer patients

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.166

21 January 2018

Role of Rab GTPases in membrane traffic and cell physiology

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.166

21 January 2018

Endocytic recycling pathways: emerging regulators of cell migration.

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.166

21 January 2018

Targeting the urokinase plasminogen activator receptor inhibits ovarian cancer metastasis

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.166

21 January 2018

Prognostic relevance of uPAR-del4/5 and TIMP-3 mRNA expression levels in breast cancer.

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.166

21 January 2018

Urokinase receptor splice variant uPAR-del4/5-associated gene expression in breast cancer: identification of rab31 as an independent prognostic factor

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.166

21 January 2018

Combined mRNA expression levels of members of the urokinase plasminogen activator (uPA) system correlate with disease-associated survival of soft-tissue sarcoma patients

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.166

21 January 2018

Urokinase plasminogen activator receptor choreographs multiple ligand interactions: implications for tumor progression and therapy

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.166

21 January 2018

Characteristics of the level-of-evidence-1 disease forecast cancer biomarkers uPA and its inhibitor PAI-1.

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.166

21 January 2018

Derailed endocytosis: an emerging feature of cancer

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.166

21 January 2018

The urokinase receptor: a ligand or a receptor? Story of a sociable molecule

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.166

21 January 2018

Overexpression of the urokinase receptor mRNA splice variant uPAR-del4/5 affects tumor-associated processes of breast cancer cells in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.166

21 January 2018

Regulation of cell signalling by uPAR.

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.166

21 January 2018

Rab GTPases as coordinators of vesicle traffic

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.166

21 January 2018

Expression of urokinase plasminogen activator and its receptor in advanced epithelial ovarian cancer patients

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.166

21 January 2018

Impact of expression differences of kallikrein-related peptidases and of uPA and PAI-1 between primary tumor and omentum metastasis in advanced ovarian cancer

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.166

21 January 2018

Identifiers

10.1515/BC.2011.166

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/21848504

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/21848504

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q55054756&oldid=1283474597"